Prognostic Value of the Preoperative Ratio of Fibrinogen to Prealbumin in Patients Undergoing Radical Resection for Lung Cancer

Author:

huang zhining1,Wang Gaoxiang1,Xu Liangdong1,Cui Shijun1,Sun Xiaohui2,Li Tian2,Wang Jun2,Xu Meiqing2,Xie Mingran1

Affiliation:

1. Anhui Medical University

2. The First Affiliated Hospital of University of Science and Technology of China

Abstract

Abstract Background and Objective It has been proven that The ratio of fibrinogen to prealbumin (FPR) has a significant effect on the prognosis of gastric cancer, colorectal cancer, esophageal cancer and other malignant tumors, but there are few studies on its effect on the prognosis of patients with resectable non-small cell lung cancer. This study aims to analyze the relationship between FPR and the postoperative clinicopathologic features and prognosis of non-small cell lung cancer. Methods The clinical follow-up pathological data of 289 patients who underwent radical resection of lung cancer and were confirmed as NSCLC by postoperative pathology were analyzed retrospectively, and the FPR values were calculated according to the serological test results within 1 week before surgery. The critical value of FPR (cut-off value) was obtained by analyzing the receiver operating characteristic curve (ROC). Kaplan-Meier survival curve and Cox proportional risk model were used to study the effect of FPR on the prognosis of patients with non-small cell lung cancer after surgery. Results 5-year survival was used as the end point to draw the ROC curve of the FPR value. When the FPR value was 10.96, the Youden index was the largest, the sensitivity was 62.4%, and the specificity was 69.6%. The cumulative five-year survival rate of the low FPR group was significantly higher than that of the high FPR group. Univariate and multivariate analysis showed that age, TNM stage and FPR level were significantly correlated with survival rate (P < 0.05). Conclusion As a new inflammatory marker, the FPR level can effectively predict the prognosis of patients with non-small cell lung cancer after radical resection.

Publisher

Research Square Platform LLC

Reference26 articles.

1. Chinese Medical Association Guidelines for the clinical diagnosis and treatment of lung Cancer (2022 edition)[J];Oncology Branch of Chinese Medical Association, Journal of Chinese Medical Association;Chin Oncol

2. Cancer treatment and survivorship statistics, 2022;Miller KD;CA Cancer J Clin,2022

3. Neutrophil/lymphocyte ratio predicts prognosis of patients with radical resection of lung adenocarcinoma [J];Wang Gaoxiang X;Chin J Lung Cancer 2018

4. Diagnostic value of combined prealbumin-to-fibrinogen and albumin-to-fibrinogen ratios in Hp-negative gastric cancer;Zhang L;Int J Biol Markers,2022

5. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer;Ying HQ;Ther Adv Med Oncol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3